SCHEMBL13619375

SCHEMBL13619375

C[C@H]1CCCCC1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12531316 1.00
SCHEMBL12531473 1.00
SCHEMBL20783128 1.00
SCHEMBL14127402 1.00
SCHEMBL867044 1.00
SCHEMBL23109968 1.00
SCHEMBL12531362 1.00
SCHEMBL11849292 0.97
SCHEMBL18611200 0.93
SCHEMBL866105 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021050556-A1 COMPOSITIONS AND METHODS FOR INHIBITING RIBOSOME INACTIVATING PROTEINS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2021-03-18 WO disclosed
EP-2123795-A1 METHOD FOR PRODUCING IODIZING AGENT AND METHOD FOR PRODUCING AROMATIC IODINE COMPOUND Japan Science and Technology Agency (JP) 2009-11-25 EP disclosed
US-7528140-B2 Substituted pyrrolo[3,2-d]pyrimidines as glycogen synthase kinase (GSK) inhibitors TEIJIN LIMITED (JP) 2009-05-05 US disclosed
US-7528140-B2 Substituted pyrrolo[3,2-d]pyrimidines as glycogen synthase kinase (GSK) inhibitors TEIJIN LIMITED (JP) 2009-05-05 US disclosed